Sycrest 5 mg and 10 mg Sublingual Tablet
*Company:
Organon Pharma (Ireland) LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 31 January 2023
File name
SYCREST-H-C-1177-IB-035-SPC-IE-en-CRT.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 15 December 2022
File name
QRD-IE-SYCREST-H-C-1177-IAIN Heist Name Change-LFT-en-CRT.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 19 November 2021
File name
SYCREST-H-C-1177-N-043-LFT-IE-en-CRT.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 01 April 2021
File name
QRD-IE-SYCREST-5mg+10mg-sublingualtablets-60tablets-LFT (002).pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to other sources of information section
Free text change information supplied by the pharmaceutical company
Update to the local representative contact details.
Updated on 14 October 2020
File name
SYCREST-H-C-1177-IB-035-SPC-IE-en-CRT (002).pdf.pdf
Reasons for updating
- Correction of spelling/typing errors
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 October 2020
File name
IE-QRD-PIL UPDATED-SYCREST-IB35+IAxx-LR-en-CRT (002).pdf.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to other sources of information section
Free text change information supplied by the pharmaceutical company
Update to the local representative contact details
Updated on 09 October 2020
File name
IE-QRD-PIL-SYCREST-IB35+IAxx-LR-en-CRT (002).pdf.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to other sources of information section
Free text change information supplied by the pharmaceutical company
Update to the local representative contact details
Updated on 12 February 2020
File name
Sycrest 5 10 mg PL UK IE clean.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 03 April 2019
File name
QRD_IE_SYCREST PIL_BRX_PRO_CRT.pdf
Reasons for updating
- New PIL for new product
Updated on 03 April 2019
File name
SYCREST-H-C-1177-II-030-SPC-IE-en-CRT.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Additional of information on falls added to section 4.4 and 4.8
Updated on 03 April 2019
File name
SYCREST-H-C-1177-II-030-SPC-IE-en-CRT.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Organon Pharma (Ireland) Limited
_1625736541.webp)
Address:
2 Dublin Landings, N Wall Quay - North Dock, Dublin, D01 V4A3Medical Information E-mail:
medinfo.roi@organon.comTelephone:
+353 1 5828250Medical Information Direct Line:
+353 1 5828260Customer Care direct line:
+353 1 5828250